LIGAND PHARMACEUTICALS INCORPORATED Finance Lease, Liability, Current
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Finance Lease, Liability, Current of $24.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2026-02-27
- 2025-12-31: Finance Lease, Liability, Current $24.00K.
- 2025-06-30: Finance Lease, Liability, Current $24.00K.
- 2025-03-31: Finance Lease, Liability, Current $24.00K.
- 2024-12-31: Finance Lease, Liability, Current $24.00K.
| Period end | Finance Lease, Liability, Current | Finance Lease, Liability, Current as first filed |
|---|---|---|
| 2025-12-31 | $24.00K 10-K · filed 2026-02-27 | |
| 2025-06-30 | $24.00K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $24.00K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $24.00K 10-K · filed 2026-02-27 | |
| 2024-09-30 | $24.00K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $12.00K 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $3.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $7.00K 10-K · filed 2025-02-28 | |
| 2023-03-31 | $43.00K 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $45.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | $48.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $50.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $52.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $45.00K 10-K · filed 2023-02-28 | $46.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $45.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $45.00K 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $5.44M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $6.59M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $13.00K 10-K · filed 2021-02-24 |